A Practitioner’s Guide to Prescribing Ethosuximide for Adults with Intellectual Disabilities
Reference36 articles.
1. Anderson, G. D. (1998). A mechanistic approach to antiepileptic drug interactions. The Annals of Pharmacotherapy, 32, 554–563. 2. Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010). Suicide-related events in patients treated with antiepileptic drugs. The New England Journal of Medicine, 363, 542–551. 3. Bachmann, K., He, Y., Sarver, J. G., & Peng, N. (2003). Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Xenobiotica, 33, 265–276. 4. Bell, G. S., Mula, M., & Sander, J. W. (2009). Suicidality in people taking antiepileptic drugs: what is the evidence? CNS Drugs, 23, 281–292. 5. Casteels, K., Van Geet, C., & Wouters, K. (1998). Ethosuximide-associated lupus with cerebral and renal manifestations. European Journal of Pediatrics, 157, 780.
|
|